Madrigal Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $24.9M | $44.2M |
| FY2010 | — | $23.5M | $31.3M |
| FY2011 | — | $14.8M | $30.1M |
| FY2012 | — | $75.1M | $81.5M |
| FY2013 | — | $49.1M | $48.5M |
| FY2014 | — | $-42.1M | $148.1K |
| FY2015 | — | $-48.9M | $306.0K |
| FY2016 | — | $36.4M | $19.1M |
| FY2017 | — | $182.3M | $148.6M |
| FY2018 | — | $477.0M | $57.4M |
| FY2019 | — | $416.6M | $46.7M |
| FY2020 | — | $240.0M | $54.0M |
| FY2021 | $0 | $196.1M | $36.3M |
| FY2022 | $49.3M | $197.4M | $331.5M |
| FY2023 | $115.5M | $405.3M | $99.9M |
| FY2024 | $117.6M | $754.4M | $100.0M |
| FY2025 | $339.9M | $602.7M | $198.7M |